Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

Dhruv Parekh

doi:10.1001/jama.2020.17022

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

Inflammation and Ageing

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	JAMA The Journal of the American Medical Association
DOIs	https://doi.org/10.1001/jama.2020.17022
Publication status	Published - 2020

Access to Document

10.1001/jama.2020.17022

Cite this

@article{3513255f3d454f15b7a33d3168695f95,

title = "Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial",

author = "Dhruv Parekh",

year = "2020",

doi = "10.1001/jama.2020.17022",

language = "English",

journal = "JAMA The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

AU - Parekh, Dhruv

PY - 2020

Y1 - 2020

UR - https://europepmc.org/articles/PMC7489418

U2 - 10.1001/jama.2020.17022

DO - 10.1001/jama.2020.17022

M3 - Article

SN - 0098-7484

JO - JAMA The Journal of the American Medical Association

JF - JAMA The Journal of the American Medical Association

ER -